Skip to main content

A Phase 2 Multicenter Study Evaluationg the Efficacy of KTE-C19 in Subjects with Relapsed/Refracory MCL

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Kite Pharma, Inc.

Start Date

September 25, 2016

End Date

September 24, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Kite Pharma, Inc.

Start Date

September 25, 2016

End Date

September 24, 2023